IRIS - Res&Arch Institutional Research Information System - Research & Archive

LISO, Arcangelo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.405
AS - Asia 1.775
EU - Europa 1.629
SA - Sud America 326
Continente sconosciuto - Info sul continente non disponibili 196
AF - Africa 49
OC - Oceania 1
Totale 6.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.342
SG - Singapore 841
IE - Irlanda 266
IT - Italia 263
BR - Brasile 252
UA - Ucraina 238
RU - Federazione Russa 230
CN - Cina 227
HK - Hong Kong 194
SE - Svezia 182
VN - Vietnam 164
DE - Germania 113
FR - Francia 93
FI - Finlandia 86
BD - Bangladesh 81
KR - Corea 75
GB - Regno Unito 57
IN - India 40
CA - Canada 34
AR - Argentina 28
TR - Turchia 24
IQ - Iraq 20
CH - Svizzera 17
UZ - Uzbekistan 16
ZA - Sudafrica 16
MX - Messico 15
NL - Olanda 15
PL - Polonia 15
SA - Arabia Saudita 13
AT - Austria 12
BE - Belgio 12
PK - Pakistan 12
MA - Marocco 11
PH - Filippine 11
CO - Colombia 10
EC - Ecuador 9
ID - Indonesia 9
VE - Venezuela 9
ES - Italia 8
EU - Europa 7
PY - Paraguay 7
GR - Grecia 5
JO - Giordania 5
LB - Libano 5
TN - Tunisia 5
CL - Cile 4
CZ - Repubblica Ceca 4
JP - Giappone 4
NP - Nepal 4
PS - Palestinian Territory 4
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
GT - Guatemala 3
IL - Israele 3
KW - Kuwait 3
LT - Lituania 3
OM - Oman 3
PE - Perù 3
SC - Seychelles 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PA - Panama 2
RS - Serbia 2
SV - El Salvador 2
AO - Angola 1
AU - Australia 1
CY - Cipro 1
EE - Estonia 1
HU - Ungheria 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MY - Malesia 1
NE - Niger 1
NI - Nicaragua 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
YT - Mayotte 1
Totale 6.192
Salva come PNG Salva come JPEG
Città #
Singapore 573
Chandler 292
San Jose 267
Dublin 265
Hong Kong 192
Ashburn 158
San Mateo 156
Jacksonville 120
Santa Clara 106
Perugia 99
Beijing 80
Boardman 79
Moscow 79
Seoul 74
Dong Ket 69
Ann Arbor 62
Medford 61
Princeton 59
Lauterbourg 57
Wilmington 54
New York 47
Altamura 43
Andover 41
Los Angeles 37
Council Bluffs 34
Lawrence 34
Piscataway 30
Ho Chi Minh City 27
Helsinki 25
Munich 24
Des Moines 20
Hanoi 19
São Paulo 17
Dallas 15
Houston 15
Phoenix 15
Woodbridge 14
Frankfurt am Main 13
Brussels 12
Falls Church 12
Izmir 12
London 12
Milan 12
Saint Petersburg 12
Johannesburg 10
Norwalk 10
Orem 10
Shanghai 10
The Dalles 10
Brooklyn 9
Montreal 9
Rome 9
San Paolo di Civitate 9
Turku 9
Belo Horizonte 8
Haiphong 8
Manchester 8
San Francisco 8
Tashkent 8
Amsterdam 7
Charlotte 7
Curitiba 7
Falkenstein 7
Baghdad 6
Buffalo 6
Coccaglio 6
Da Nang 6
Denver 6
Rio de Janeiro 6
Riyadh 6
Asunción 5
Atlanta 5
Auburn Hills 5
Chennai 5
Fairfield 5
Porto Alegre 5
Stockholm 5
Toronto 5
Uberlândia 5
Warsaw 5
Amman 4
Ankara 4
Bologna 4
Buenos Aires 4
Campinas 4
Columbus 4
Dammam 4
Florence 4
Guangzhou 4
Guayaquil 4
Hefei 4
Las Vegas 4
Mexico City 4
New Delhi 4
Philadelphia 4
Secaucus 4
Tunis 4
Baku 3
Basra 3
Boston 3
Totale 3.776
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 174
Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity? 165
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1) 160
Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. 145
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 144
Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. 124
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 121
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 119
Aberrant hypermutation of PIM1, PAX5, RhoH/TTF and cMYC in nodular lymphocyte predominance Hodgkin's disease 117
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants 117
Exon-12 nucleophosmin (NPM) mutation and aberrant cytoplasmic expression of NPM protein in leukemia cell line OCI-AML3 116
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia. 113
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 112
BRAF mutations in hairy-cell leukemia. 109
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia 108
CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice. 108
WESTERN BLOT IDENTIFICATION OF NPM1 LEUKEMIC MUTANTS IN CYTOLOGICAL AML SAMPLES: A POWERFUL DIAGNOSTIC TECHNIQUE 107
Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1). 107
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. 106
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. 106
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 105
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML. 102
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin 101
Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML. 101
Evolving concepts in the pathogenesis of hairy-cell leukaemia. 98
CYTOPLASMIC MUTATED NUCLEOPHOSMIN DEFINES THE MOLECULAR STATUS OF A SIGNIFICANT FRACTION OF MYELOID SARCOMAS 98
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice 98
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 96
Absence of nucleophosmin leukemic mutants in B and T cells from AML with NPM1 mutations: Implications for the cell of origin of NPMC plus AML 91
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP6 88
Seasonality of birth for skin melanoma deserves further investigation 87
Treating two concurrent B-cell and T-cell lymphoid neoplasms with alemtuzumab monotherapy 85
Nucleophosmin leukaemic mutants contain C-terminus peptides that bind HLA class I molecules. 85
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. 84
Linking surgical specimen length and examined lymph nodes in colorectal cancer patients 84
Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors 83
PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia 82
High anti-PLAC1 antibody levels in idiopathic infertile patients with repeated unexplained implantation failure 80
The Crosstalk between GPR81/IGFBP6 Promotes Breast Cancer Progression by Modulating Lactate Metabolism and Oxidative Stress 79
Vaccine therapy of B cell malignancies: Different strategies for a novel approach 76
Selective silencing of the NPM1 mutant protein and apoptosis induction upon ATRA in vitro treatment of AML cells carrying NPM1 mutations. 75
Haploidentical peripheral-blood stem-cell transplantation for ALK-positive anaplastic large-cell lymphoma. 75
Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines 74
Dissecting the Hierarchical Level of Hematopoietic Progenitors' Involvement in AML with NPM1 Gene Mutation and Their Engraftment Potential in Immunocompromised Mice. 73
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 73
Insertions generating the 5'RUNX1/3'CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints. 72
SELECTIVE SILENCING OF THE NPM1 MUTANT PROTEIN AND APOPTOSIS INDUCTION UPON ATRA IN VITRO TREATMENT OF AML CELLS CARRYING NPM1 MUTATIONS 72
Seasonal Variation in Skin Cancer Diagnosis 72
From fever to immunity: A new role for IGFBP-6? 72
PLAC1 immunization does not induce infertility in mice 71
Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling 67
Minimally invasive surgical versus transcatheter aortic valve replacement: A multicenter study 66
In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. 63
Seasonal variation in the month of birth in patients with skin cancer 63
Droplets generated from toilets during urination as a possible vehicle of carbapenem-resistant Klebsiella pneumoniae 62
null 62
Western blot identification of NPM1 leukemic mutants in cytological AML samples: A powerful diagnostic technique 57
EVIDENCE FOR CD34+HEMATOPOIETIC PROGENITOR CELL INVOLVEMENT IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION: IMPLICATIONS FOR THE CELL OF ORIGIN 57
Insulin-like growth factor binding protein 6 in rheumatoid arthritis: A possible novel chemotactic factor? 57
IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis 56
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 52
CD34-POSITIVE HEMATOPOIETIC PROGENITOR CELLS ARE INVOLVED IN ACUTE MYELOID LEUKEMIA WITH NPM1 GENE MUTATION 51
Tumor Protein D52 (TPD52): A Novel B Cell/Plasma Cell Molecule Identified through a Proteomic Approach and Characterized by Unique Expression Pattern and Ca2+-Dependent Association with Annexin VI 47
Proteasome inhibitors as a possible therapy for SARS-CoV-2 44
Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes 43
Multidrug-Resistant Bacteria Contaminating Plumbing Components and Sanitary Installations of Hospital Restrooms 43
Evidence for CD34+Hematopoietic Progenitor Cell Involvement in Acute Myeloid Leukemia with NPM1 Gene Mutation: Implications for the Cell of Origin 42
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 40
IGFBP-6 Network in Chronic Inflammatory Airway Diseases and Lung Tumor Progression 39
Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells 39
Insulin Growth Factor Binding Protein-6 and the Liver 35
Redox Biology and Insulin-like Growth Factor-Binding Protein-6: A Potential Relationship 34
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study 29
Activity of a foam in preventing rebound of vancomycin-resistant Enterococcus faecium-containing droplets generated from the toilet bowl 22
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL) 19
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 18
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid Leukemia 17
High anti PLAC 1 antibody levels in idiopathic infertile patients with repetaed unexplained implantation failure 17
USE OF ANTI-PLAC1 PROTEIN ANTIBODIES AS BIOMARKERS OF INFERTILITY, DIAGNOSTIC KIT FOR THE DETECTION OF THE IMMUNE RESPONSE AGAINST PLAC1 AND USE OF PLAC1 PROTEIN IN THERAPEUTIC AND CONTRACEPTIVE FIELDS 15
Preliminary evidence for high anti-PLAC1 antibody levels in infertile patients with repeated unexplained implantation failure 15
Reduced percentage of postovulatory natural killer cells associated with impaired cytokines network in the secretory endometrium of infertile PCOS women 14
A novel translocation t(14;15)(q32;q24) bearing deletion on der(14) in Philadelphia-positive chronic myeloid leukemia 12
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi 12
Use of design of experiments to optimize the production of microbial probiotic biofilms 12
Hematopoietic Stem Cell Transplantation: A Bioethical Lens 11
Genome-wide computational approach for the prediction of duplications generating protein localization signals 10
Rapid long-lasting biochemical and radiological response to sorafenib in a case of advanced hepatocellular carcinoma 8
DONOR SELECTION FOR ALLOGENIC HAEMOPOIETIC STEM CELL TRANSPLANTATION: CLINICAL AND ETHICAL CONSIDERATIONS 8
Febrile temperature reprograms by redox-mediated signaling the mitochondrial metabolic phenotype in monocyte-derived dendritic cells 7
IGFBP-6 as a potential therapeutic target in musculoskeletal disorders 3
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin? 3
Totale 6.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.649
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.649
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 0 0 4 30 19 3 4 172 6 9 51 66
2022/2023898 63 155 9 72 69 93 0 41 346 9 30 11
2023/2024292 27 29 21 6 3 2 76 9 23 6 42 48
2024/2025965 25 69 97 23 121 44 36 74 190 63 142 81
2025/20262.420 163 131 105 215 289 199 335 205 302 268 107 101
2026/2027226 61 96 69 0 0 0 0 0 0 0 0 0
Totale 6.381